Join us to explore the latest advancements in dementia research and the emergence of novel disease-modifying agents for early Alzheimer's Disease.

Australia is on the brink of approval and availability of at least two agents. Comprehensive care will stretch from genetic and risk factor screening, new diagnostic pathways, treatment delivery, adverse events monitoring, follow-up, and after care.

This is an important shift in dementia treatment and care, with profound implications for all health sectors, from primary to tertiary care and substantial shifts in health and aged care budgets.

Roll-out in the Hunter

This forum will provide an in-depth overview of the evidence, care pathways, and timelines related to these agents, focusing on their clinical translation within the Hunter region.

Why come along?

Gain insights from Hunter New England dementia expert Professor Peter Schofield, as well as leading researchers, pharmaceutical medical advisors and persons with lived experiences about the breakthroughs in dementia treatment. Following the event, you'll have the opportunity to network and mingle with fellow guests.

When: Tuesday 2 July, 2024
Time: 5.30 pm - 8.00 pm

- Enjoy light nibbles, tea, and coffee from 5.30 pm
- The event will take place from 6.00 pm - 7.30 pm
- Light refreshments and networking from 7.30 pm - 8.00 pm

Where: Caves Theatre, Level 4 East, Hunter Medical Research Institute
Tickets: Free, however please register via the 'Get Tickets" link above

This venue is accessible for wheelchair access